CONTACT
+91 80 2808 2808
ContactUs.BBL@biocon.com

Press Releases 2019

Biocon Biologics  /  News – Posts  /  Press Releases  /  Press Releases 2019

Biocon Biologics Symposium on ‘100 years of Insulin – Delivering on Universal Access & Equitable Care’ Resonates Well with Leading KOLs at IDF Congress 2019

  • Posted by: Biocon Biologics

Biocon Biologics Takes Forward Its Mission to Unlock Universal Access to Insulins Globally

  • Posted by: Biocon Biologics

Biocon and Mylan Launch Trastuzumab Biosimilar, Ogivri™ (trastuzumab-dkst), in the U.S.

  • Posted by: Biocon Biologics

USFDA Approves Biocon’s sBLA for Pegfilgrastim New Manufacturing Facility

  • Posted by: Biocon Biologics

Kiran Mazumdar-Shaw Conferred with Lifetime Achievement Award by Indian Council of Medical Research

  • Posted by: Biocon Biologics

Biocon Features in the Prestigious ASIA IP ELITE List for the Fourth Consecutive Year

  • Posted by: Biocon Biologics

Biocon’s Biologics Drug Products Facility in Bengaluru Receives EIR from U.S. FDA

  • Posted by: Biocon Biologics

Biocon Moves Up to Rank No. 6 on Science Careers’ Top 20 Global Pharma & Biotech Employers List 2019

  • Posted by: Biocon Biologics

Biocon Q2FY20 Earnings Revenue at Rs 1,611 Cr, Up 17 %; EBITDA at Rs 441 Cr, Up 12%; Net Profit (excluding exceptional item) at Rs 189 Cr, Up 3%

  • Posted by: Biocon Biologics

Biocon Biologics & Just – Evotec Biologics Sign Licensing Deal for a Biosimilar Asset

  • Posted by: Biocon Biologics
Share